US Stocks
/
Grace Therapeutics, Inc. Share Price

Grace Therapeutics, Inc. Share Price

NASDAQ: GRCE | Micro Cap
$2.08
+0.00 (0.00%) Last updated on 08 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Grace Therapeutics, Inc. Stock Performance

Open
$2.07
Prev. Close
$2.08
Circuit Range
N/A
Day Range
$2.07 - $2.10
Year Range
$1.79 - $5.15
Volume
1,873
Average Traded
$2.09

Grace Therapeutics, Inc. Share Price Today

As of 8 October 2026, Grace Therapeutics, Inc.'s share price is $2.08. The stock opened at $2.07, compared to its previous close of $2.08. During today's trading session, Grace Therapeutics, Inc.'s share price traded between $2.07 and $2.10, with an average price of $2.09. Over the past 52 weeks, the stock has recorded a high of $5.15 and a low of $1.79. In terms of performance, Grace Therapeutics, Inc.'s share price has declined by 7.96% over the last six months and is down 34.59% on a year-on-year basis.

Grace Therapeutics, Inc. Share Price Chart

$2.07$2.10
L
Show Current Price
H

Grace Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$25.14M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.96
Revenue (TTM)
$0.00
Return On Equity (TTM)
-41.94%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-1579.79%

Grace Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$0.94-$2.32-$1.18-$15.79
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-146.81%49.14%-1238.14%

Grace Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20252026
Revenue$0.00$0.00
Net Profit-$9.57-$7.79
Net Profit MarginN/AN/A
Income ChangeN/A18.60%

About Grace Therapeutics, Inc.

Grace Therapeutics Inc is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its development pipeline consists of the following product candidates: GTx-104, a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage (aSAH); GTx-102, targeted for the treatment of ataxia-telangiectasia (A-T) in a pediatric population; and GTx-101, a topical bio adhesive film-forming bupivacaine spray for Postherpetic Neuralgia (PHN), which can be persistent and often causes debilitating pain following infection by the shingles virus. The company has one reportable operating segment: the development and commercialization of pharmaceutical applications of its patents and licensed rights.

Grace Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.11
$2.10
-2.10%
Sep 2026
$2.12
$2.14
-1.15%
Aug 2026
$2.13
$2.17
+3.59%
Jul 2026
$2.32
$2.09
-7.93%
Jun 2026
$2.60
$2.27
-12.36%
May 2026
$2.30
$2.59
+14.60%
Apr 2026
$4.78
$2.26
-51.29%
Mar 2026
$4.19
$4.64
+7.91%
Feb 2026
$3.69
$4.30
+17.49%
Jan 2026
$3.51
$3.66
+4.57%
Dec 2025
$3.19
$3.50
+10.06%
Nov 2025
$3.14
$3.18
+0.00%

GRCE Share Price FAQs

What is Grace Therapeutics, Inc. share price today?

chevron-up
Grace Therapeutics, Inc. share price today is $2.08 as on October 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Grace Therapeutics, Inc. stock?

chevron-up
The 52 week high of Grace Therapeutics, Inc. stock is $5.15, while the 52 week low is $1.79 as of 8 Oct '26.

What is GRCE's market capitalisation today?

chevron-up
GRCE market capitalisation is $25.14M as of October 8, 2026, at 4:07 pm IST.

What is GRCE's net income for the last quarter?

chevron-up
GRCE's net income for the last quarter is -15.79B USD.

What is the 5 year returns of GRCE?

chevron-up
The 5 year returns of GRCE is -79.24% as on 8 Oct '26.

What is the high & low stock price of GRCE today?

chevron-up
GRCE stock price hit a high of $2.10 and low of $2.07 as of 8 Oct '26.

Can I buy GRCE shares in India?

chevron-up
Yes. You can buy GRCE in India by opening an international trading account.